ADVIA Centaur C-peptide (CpS) Master Curve Material (MCM), ADVIA Centaur Insulin (IRI) Master Curve Material (MCM)
Single (Specified) Analyte Controls (Assayed And Unassayed). 510(k) K142864, from Siemens Healthcare Diagnostics, Inc. (Tarrytown, NY). Product code JJX, class 1.
As of Nov 18, 2026, K142864 is an FDA 510(k) held by Siemens Healthcare Diagnostics, Inc., substantially equivalent on Oct 29, 2014 after 28 days, with no recalls tied to it in FDA's recall database.
- Substantially equivalent: Oct 29, 2014
- Review time: 28 days
- Recalls: 0
- Cited as a predicate by: 1 device
Indications for Use
As the 510(k) summary states them, read from FDA's summary PDFThe ADVIA Centaur® C-peptide (CpS) Master Curve Material is for in vitro diagnostic use in the verification of calibration and reportable range of the ADVIA Centaur C-peptide assay.
Predicate Devices
The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF- Chiron Diagnostics Automated Chemiluminescence System (Asc) Centaur AnalyzerK971418 · Chiron Diagnostics Corp. · Jul 17, 1997
- Bayer Advia Centaur Automated Chemiluminescence AnalyzerK032525 · Bayer Healthcare, LLC · Sep 9, 2003
- Modification To Bayer Advia Centaur Automated Chemiluminescence AnalyzerK041133 · Bayer Healthcare, LLC · Jul 2, 2004
- Elecsys Insulin Calcheck 5K101075 · Roche Diagnostics Corp. · Jun 11, 2010
Cited as a Predicate
1 later 510(k) summary names this device as a predicate- ADVIA Centaur Insulin (IRI) Master Curve Material (MCM), ADVIA Centaur (IRI) CalibratorK162538 · Siemens Healthcare Diagnostics · Nov 17, 2016
Record
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Oct 1, 2014
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1660
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files